Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Cardiac Rhythm Management Devices Market

  • MAR2978998
  • 202 Pages
  • March 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
The Global Cardiac Rhythm Management Devices Market is valued at USD XX Billion in 2016 and is poised to reach USD XX Billion by 2022 growing at a CAGR of XX% during the forecast period. Cardiac rhythm management devices are implantable devices used for cardiac resynchronization to patients suffering from cardiac arrhythmias. The demand for such devices has risen over the years due to increased reported cases of cardiovascular diseases (CVDs). According to WHO, more than 17.7 million people died from CVDs in 2015 representing 31% of all global deaths. With the number of people suffering from arrhythmias is expected to grow, the requirement for such devices is expected to expand multi-fold.

Market Dynamics

The major growth drivers of the Global Cardiac Rhythm Management Devices Market are technological developments, rising geriatric population, increased patient awareness and prevalence of heart diseases due to obesity and improper lifestyle.

However, parallel factors like shortage of skilled professionals such as technicians and the high cost of devices restrain the growth of the market.

Rising number of cardiac patients in emerging economies together with the commoditization of cardiac rhythm management devices for large-scale use provide opportunities for market players.

Market Segmentation

The market is segmented based on the product, into defibrillators, pacemakers and cardiac resynchronization therapy (CRT)devices. Each of these is divided into sub-segments. Pacemakers can be either implantable or external. CRT can be of type CRT-P(with pacemaker function) or CRT-D(with pacemaker and ICD functions). Similarly, defibrillators can be either implantable or external. Among the broad segments, defibrillators segment is expected to account for the largest share during the forecast period.

Regional/Geographic Analysis

In terms of geography, Cardiac Rhythm Management Devices Market is divided into North America, Europe, Asia-Pacific and LAMEA(Latin America, Middle East & Africa). North America has the major share of the market while Asia-Pacific is expected to be the fastest growing during the forecasted years.

Key Players

Some of the major players in the market include Medtronic, St. Jude Medical (Abbott), Boston Scientific, Biotronik, LivaNova (Sorin), Medico, IMZ, Pacetronix, Qinming Medical and

Cardioelectronica. Medtronic leads the market in terms of market share.

The report contains comprehensive analysis on:

--> Global Cardiac Rhythm Management Devices Market Segments

--> Global Cardiac Rhythm Management Devices Market Drivers, Restraints and Opportunities

--> Global Cardiac Rhythm Management Devices Market Size & Forecast 2016 to 2022

--> Supply & Demand Value Chain

--> Global Cardiac Rhythm Management Devices Market Current Trends

--> Competition & Major Companies

--> Technology and R&D Status

--> Porters Five Force Analysis

--> Strategic and Critical Success Factor Analysis of Key Players

Regional analysis for Global Cardiac Rhythm Management Devices Market includes

--> North America

>> US and Canada

--> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

--> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

--> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

--> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

--> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Report Highlights::

--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

--> Consumer and Pricing Analysis

--> Market dynamics of the industry

--> In-depth Market Segmentation

--> Historical and Projected Market Sizing in terms of volume and value

--> Recent market trends and Impact Factors

--> R&D Status and Technology Overview

--> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390